Pharmacological and clinical feature of rebamipide: new therapeutic targets

Pharmacological and clinical feature of rebamipide: new therapeutic targets

Rebamipide is a cytoprotector developed in Japan where it has been successfully used for the treatment of stomach diseases for 30 years. Initially discovered effects of the drug included the induction of prostaglandins and the elimination of free oxygen radicals. Recent studies discovered new therap...

Full description

Bibliographic Details
Main Authors:	M. Yu. Zvyaglova, O. V. Knyazev, A. I. Parfenov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2020-02-01
Series:	Терапевтический архив
Subjects:	rebamipide cytoprotector enteropathy disaccharidases peptic ulcer disease ulcerative colitis radiation colitis oral mucositis dry eye syndrome
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/33918/pdf

Similar Items

The Effectiveness of Rebamipide in Combined Treatment of Patients with Peptic Ulcer of the Stomach and Duodenum
by: Demydova A., et al.
Published: (2017-03-01)

Rebamipide: evidence base for use in gastroenterology
by: D. N. Andreev, et al.
Published: (2020-12-01)

The effect of the FODMAP and rebamipid diet on the activity of disaccharidases in patients with enteropathy with impaired membrane digestion
by: Elena V. Baulo, et al.
Published: (2023-03-01)

Evaluation of efficacy and safety of rebamipide use in the triple therapy for Helicobacter pylori eradication: a pilot study
by: D. T. Dicheva, et al.
Published: (2018-04-01)

Enteropathy with impaired membrane digestion and the prospects for cytoprotective therapy
by: A. I. Parfenov, et al.
Published: (2021-02-01)

CLINICAL AND PHARMACOLOGICAL CHARACTERISTICS OF THE USE OF REBAMIPIDE IN DISEASES OF THE GASTROINTESTINAL TRACT LITERATURE REVIEW
by: V. I. SIMANENKOV, et al.
Published: (2016-12-01)

Food intolerances and the small intestine
by: Asfold I. Parfenov
Published: (2022-02-01)

Rebamipide: A novel agent in the treatment of recurrent aphthous ulcer and Behcet′s syndrome
by: Mohan H Kudur, et al.
Published: (2013-01-01)

Disaccharidase Deficiency in Pediatric Patients with Inflammatory Bowel Disease
by: Chance S. Friesen, et al.
Published: (2022-01-01)

Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes
by: Saurabh Shrivastava, et al.
Published: (2018-01-01)

Hydrogel Formulations Incorporating Drug Nanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Model for Oral Mucositis
by: Noriaki Nagai, et al.
Published: (2020-06-01)

Preventive Effect of Rebamipide Gargle on Chemoradiotherpy-Induced Oral Mucositis in Patients with Oral Cancer: a Pilot Study
by: Takashi Yasuda, et al.
Published: (2011-11-01)

Plants with Anti-Ulcer Activity and Mechanism: A Review of Preclinical and Clinical Studies
by: Prayoga DK, et al.
Published: (2024-02-01)

Rebamipide: New opportunities of gastroenteroprotection
by: V I Simanenkov, et al.
Published: (2015-12-01)

Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre
by: Kalpna Jain, et al.
Published: (2023-01-01)

Relationship between mucosal healing by tacrolimus and relapse of refractory ulcerative colitis: a retrospective study
by: Ayumi Ito, et al.
Published: (2020-06-01)

Association between platelet count and mucosal healing in Japanese patients with ulcerative colitis: a cross-sectional study
by: Shinya Furukawa, et al.
Published: (2020-11-01)

The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease
by: Onur Keskin, et al.
Published: (2023-02-01)

Oral indicators of ulcerative colitis: A rare case report and review of literature
by: Ashalata Ganepalli, et al.
Published: (2012-01-01)

Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT Pathways with Rebamipide Attenuates Acetic Acid-Induced Colitis in Rats
by: Maha M. Abdel-Fattah, et al.
Published: (2023-04-01)

Editorial: Recent advances and new biomarkers in ulcerative colitis
by: Tsvetelina Velikova, et al.
Published: (2023-05-01)

Novel Sustained-Release Drug Delivery System for Dry Eye Therapy by Rebamipide Nanoparticles
by: Noriaki Nagai, et al.
Published: (2020-02-01)

Gelsolin as a Potential Biomarker for Endoscopic Activity and Mucosal Healing in Ulcerative Colitis
by: Keiko Maeda, et al.
Published: (2022-04-01)

Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing
by: Leonie Wittner, et al.
Published: (2023-04-01)

Artificial intelligence for endoscopy in inflammatory bowel disease
by: Kento Takenaka, et al.
Published: (2022-04-01)

A super "lead-pipe" colon: radio-pathological correlation of long-standing ulcerative colitis
by: A Weinstein, et al.
Published: (2008-03-01)

Antioxidant and Anti-Inflammatory Effects of Gel and Aqueous Extract of Melilotus officinalis L. in Induced Ulcerative Colitis: A Rattus norvegicus Model
by: Ali Reza Safarpour, et al.
Published: (2015-06-01)

Rebamipide increases the disaccharidases activity in patients with enteropathy with impaired membrane digestion. Pilot study
by: A I Parfenov, et al.
Published: (2019-02-01)

Asthma and the risk of gastrointestinal disorders: a Mendelian randomization study
by: Dennis Freuer, et al.
Published: (2022-03-01)

Potent Intestinal Mucosal Barrier Enhancement of <i>Nostoc commune</i> Vaucher Polysaccharide Supplementation Ameliorates Acute Ulcerative Colitis in Mice Mediated by Gut Microbiota
by: Min Guo, et al.
Published: (2023-07-01)

Endoscopic and Histologic Predictors of Outcomes in Pediatric Ulcerative Colitis—Caveat Emptor
by: Lorraine Stallard, et al.
Published: (2021-06-01)

Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis
by: Haotian Chen, et al.
Published: (2021-06-01)

Is histological remission of ulcerative colitis achievable?
by: Oleg V. Knyazev, et al.
Published: (2021-08-01)

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
by: Alix Démaris, et al.
Published: (2022-09-01)

The oral bacterial microbiota facilitates the stratification for ulcerative colitis patients with oral ulcers
by: Jun Xu, et al.
Published: (2023-11-01)

The Efficacy and Safety of Rebamipide Ophthalmic Suspension (OPC-12759) in Patients with Dry Eye Disease: A Systematic Review of Randomized Controlled Trials
by: Antonio Ballesteros-Sánchez, et al.
Published: (2023-11-01)

The effects of rebamipide, sucralfate, and rifaximin against inflammation and apoptosis in radiation-induced murine intestinal injury
by: Won Moon, et al.
Published: (2022-12-01)

Polydopamine-cladded montmorillonite micro-sheets as therapeutic platform repair the gut mucosal barrier of murine colitis through inhibiting oxidative stress
by: Gaolong Lin, et al.
Published: (2023-06-01)

Complete elimination of cytomegalovirus without antiviral therapy after systemic mesenchymal stromal cell transplantation in a patient with ulcerative colitis (a clinical case)
by: O V Kniazev, et al.
Published: (2012-12-01)

THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE
by: O. V. Knyazev, et al.
Published: (2018-01-01)